CTOs on the Move

Qdivision

www.qdivision.io

 
QDivision is a team of highly capable, highly motivated individuals solving complex problems in the transportation and moving industry through the application of user centered design and cutting edge technology. At QDivision, innovation and technology are core components of our products. Our brilliant software engineers are given the freedom to use their talents and creativity to apply technology in the most effective and efficient manner possible. Our mission is simple: Identify, develop and leverage cutting edge technology for the benefit of the transportation and moving industries.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

IdentifySensors

IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.

Floriponics

Floriponics is a Wasilla, AK-based company in the Computers and Electronics sector.

BlueVoyant

BlueVoyant combines outstanding talent from the private sector and from the cyber intelligence services of the U.S., Israel, and the U.K. to provide a critical additional layer of defense to companies managing their own cyber threat protection. We have unique capabilities to identify actionable threat intelligence from outside your perimeter, so that your company can protect itself from advanced cyber attacks. In addition, BlueVoyant provides complete Managed Cybersecurity Services to make managing your defenses more efficient. BlueVoyant`s experts have led some of the most high-profile investigations into attacks perpetrated by criminal and nation state adversaries. We have experience with corporate investigations involving ransomware, malware infections, insider threat, data theft, and business email compromise

Axio

Axio is the leader in SaaS-based cyber management software, which empowers security leaders to build and optimize security programs and quantify risk in financial terms. Axio360 is the only cyber risk management platform to align security leaders, business leaders, and Boards of Directors around a single source of truth about their most critical corporate risks. Since 2016, Axio has been a trusted partner to many of the world`s leading critical infrastructure, energy, manufacturing, and financial services companies, helping drive better visibility and decision-making about cybersecurity priorities and investments.

NEAR Protocol

NEAR is a blockchain protocol designed to bridge the adoption gap for mainstream commercial DApps.